Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: National Stock Exchange of India Ltd. (Stock Code: BSE Limited (Stock Code: 500124) New York Stock Exchange Inc. (Stock Code: RDY) NSE IFSC Ltd. (Stock Code: DRREDDY) This is in furtherance to our intimation dated December 17, 2022, informing the exchange that our wholly own

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code:
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
This is in furtherance to our intimation dated
December 17, 2022, informing the exchange that our wholly owned subsidiary Dr. Reddy's Research and Development B. V. (DRRDBV), has entered
into an Asset Purchase Agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Zernikedreef
12, 2333, CL Leiden, The Netherlands.
In this regard, we would like to inform you that
DRRDBV has completed the above said transaction on Thursday, December 22, 2022 and the Asset Purchase Agreement is now effective. The
details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015
dated September 9, 2015, have already been made available vide the Annexure A' of our intimation dated December 17, 2022.
Kindly take the above on your record.
For Dr. Reddy's Laboratories Limited
/s/ K Randhir Singh
K Randhir Singh
Company Secretary, Compliance Officer and Head
Last updated: Dec 23, 2022